Live Breaking News & Updates on Health happiness group

Stay informed with the latest breaking news from Health happiness group on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Health happiness group and stay connected to the pulse of your community

New chair at Alliance Pharma | Insider Media

New chair at Alliance Pharma | Insider Media
insidermedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermedia.com Daily Mail and Mail on Sunday newspapers.

Chippenham , Wiltshire , United-kingdom , Hong-kong , Jo-lecouilliard , Richard-jones , Health-happiness-group , Hong-kong-stock-exchange , Alliance-pharma , Camillo-pane , Happiness-group ,

UNITED CAPS Valframbert Plant Customer Event Showcases Innovative Dairy and Infant Nutrition Caps and Closures

UNITED CAPS Valframbert Plant Customer Event Showcases Innovative Dairy and Infant Nutrition Caps and Closures

Luxembourg , France , Valframbert , Basse-normandie , French , Happiness-group , International-sustainability , Health-happiness-group , Biostime-nutrition , Infant-nutrition , Benoit-henckes

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2021 Results

09.03.2022 - ChromaDex Corp. (NASDAQ:CDXC) today announced fourth quarter and fiscal year 2021 financial results. Fourth Quarter 2021 and Recent Highlights Total net sales were $17.8 million, up 15% year over year. Tru Niagen net sales were $14.1 million, a 14% ...

China , United-states , Sinopharm-xingsha , Tru-niagen , Exchange-commission , Walmart , Chromadex-corporation , Securities-exchange , Health-happiness-group , Chromadex-external-research-program , Happiness-group , Rob-fried

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2021 Results

Total net sales of $67.4 million for the full year, up 14% from the prior year, with $56.7 million from Tru Niagen® and gross margin of 61.5%. Total net sales of $17.8 million for the three months ended December 31, 2021, up 15% from the prior year quarter.LOS ANGELES--(BUSINESS WIRE)--$CDXC #earnings--ChromaDex Cor...

China , United-states , Brianna-gerber , Alex-worsham , Sinopharm-xingsha , Tru-niagen , Walmart , Nasdaq , Chromadex-external-research-program , Exchange-commission , Chromadex-corp , Chromadex-corporation

Product profiles: Top stories on the new product innovations in the APAC beauty space

Product profiles: Top stories on the new product innovations in the APAC beauty space
In our round-up of the recent product developments in the Asia Pacific beauty and personal care market, we highlight the latest innovations from Swisse, Kosé, Antipodes and more.
1 – In and out beauty: Swisse extends revamped beauty range to complement supplement business
Swisse is ramping up new product development for its revamped beauty range as part of its focus into the ‘beauty in and out’ market in Australia and worldwide.
Owned by the Health & Happiness Group (H&H), the wellness and vitamin brand relaunched its skin care business in April 2020, to complement its supplement business.

Australia , Japan , India , United-kingdom , France , French , Japanese , Nick-mann , Elizabeth-barbalich , Marie-drago , Health-happiness-group , Happiness-group

In and out beauty: Swisse extends revamped beauty range to complement supplement business

In and out beauty: Swisse extends revamped beauty range to complement supplement business
Swisse is ramping up new product development for its revamped beauty range as part of its focus into the ‘beauty in and out’ market in Australia and worldwide.
Owned by the Health & Happiness Group (H&H), the wellness and vitamin brand relaunched its skin care business in April 2020, to complement its supplement business.
“
Although we have had a skin care range for several years, we are increasingly making it a core focus of the business. We have heavily invested time, effort, and innovation in skin care as it is organically symbiotic to our vitamin and supplement products,” said Nick Mann, managing director at Swisse Wellness.

China , Australia , Indonesia , India , United-kingdom , Nick-mann , Kmart , Health-happiness-group , Big-w , Happiness-group , Swisse-beauty , Renew-booster

Bod Australia (ASX:BDA) begins expansion efforts with first U.S. order

Bod Australia (ASX:BDA) begins expansion efforts with first U.S. order
themarketherald.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketherald.com.au Daily Mail and Mail on Sunday newspapers.

Australia , United-states , America , Jo-patterson , Hong-health-happiness-group , Health-happiness-group , Bod-australia , Happiness-group , Hong-kong-listed-health , North-america , ஆஸ்திரேலியா , ஒன்றுபட்டது-மாநிலங்களில்

Nalu Bio has Successfully Synthesized Pure, High-quality CBD for Scale and Closed Its Seed Financing Round

Share this article
Share this article
SAN FRANCISCO, Jan. 7, 2021 /PRNewswire/ -- Nalu Bio, Inc. today announced the successful organic synthesis of CBD (cannabidiol) utilizing its proprietary technology platform, closure of its seed financing, and the successful recruitment of a world-class team of life science and consumer packaged goods professionals to develop and scale the company's innovative technology. Nalu Bio's vision for the organic synthesis and cost-effective mass production of CBD mimics the history of aspirin - the therapeutic value of aspirin for pain relief was uncovered, is now mass-produced in the lab, and has become the most commonly used drug in the world.

Nalu-bio , Phyllis-whiteley , Caitlyn-krebs , Alex-dorenbaum , Randall-ussery , Matthew-roberts , Reneo-pharmaceuticals , Genentech , Prnewswire-nalu-bio-inc , Nalu-bio-inc , Clinical-professor-at-stanford-school-of-medicine , Lumena-pharmaceuticals